Black Diamond Financial LLC Has $643,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Black Diamond Financial LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,272 shares of the healthcare conglomerate’s stock after acquiring an additional 51 shares during the period. Black Diamond Financial LLC’s holdings in UnitedHealth Group were worth $643,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the business. BCGM Wealth Management LLC grew its position in UnitedHealth Group by 3.8% during the 4th quarter. BCGM Wealth Management LLC now owns 3,858 shares of the healthcare conglomerate’s stock worth $1,952,000 after acquiring an additional 143 shares during the last quarter. World Equity Group Inc. grew its position in UnitedHealth Group by 108.5% during the 4th quarter. World Equity Group Inc. now owns 2,070 shares of the healthcare conglomerate’s stock worth $1,047,000 after acquiring an additional 1,077 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its position in UnitedHealth Group by 1.2% during the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 208,818 shares of the healthcare conglomerate’s stock worth $105,633,000 after acquiring an additional 2,400 shares during the last quarter. Ascent Wealth Partners LLC grew its position in UnitedHealth Group by 0.7% during the 4th quarter. Ascent Wealth Partners LLC now owns 19,485 shares of the healthcare conglomerate’s stock worth $9,857,000 after acquiring an additional 142 shares during the last quarter. Finally, Lansing Street Advisors grew its position in shares of UnitedHealth Group by 3.7% in the 4th quarter. Lansing Street Advisors now owns 766 shares of the healthcare conglomerate’s stock valued at $388,000 after buying an additional 27 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Stephens boosted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Performance

UNH stock opened at $465.58 on Monday. The firm has a market cap of $428.46 billion, a PE ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business has a 50 day moving average of $519.27 and a 200-day moving average of $560.44. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.